This is a procedure to try and fix damage to the spinal cord. It's like trying to repair a broken wire inside your back. The goal is to help the nerves work better after an injury or illness.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Spinal cord regeneration is the effort to repair a damaged spinal cord so that lost movement, sensation or body functions come back. The spinal cord carries signals between the brain and the rest of the body. After an injury, many of the nerve fibers that cross the damaged area stop carrying those signals, which is why weakness, numbness and changes in bladder, bowel or sexual function below the injury are often long-lasting. Recovery that happens on its own typically levels off around a year after the injury. No treatment that regrows spinal cord tissue has been approved in the United States. Researchers are testing several approaches in clinical trials: transplanting cells, including stem cells, to replace damaged cells or support surviving ones; growth-promoting substances and engineered scaffolds meant to help nerve fibers grow across the injury; and electrical stimulation of the spinal cord. Stimulation does not regrow tissue. Instead, it makes surviving nerve circuits easier to activate, so that intensive therapy can strengthen them. Most cell therapy studies are still small and early-stage. This topic is mainly relevant to people living with a spinal cord injury who are considering a clinical trial or a newer stimulation treatment. Rehabilitation (physical and occupational therapy, training in daily skills and assistive devices) remains the standard way to regain function and independence, and research treatments are added to it rather than replacing it. One noninvasive stimulation system, the ARC-EX System from Onward Medical, sends current through electrodes placed on the skin over the spine and has authorization from the US Food and Drug Administration (FDA). It is authorized for adults aged 18 to 75 with a long-standing, incomplete injury at neck level (some movement or feeling remains below the injury), used together with task practice in a clinic to improve hand strength and sensation. The FDA noted that it has not been shown to improve everyday function, and it is not for people who have an active implanted electrical device, such as a pacemaker, or who wear a defibrillator vest.
Preparation usually starts with screening for a specific study. Trials set narrow entry rules, often based on the level of the injury, whether it is complete (no movement or feeling below the injury) or incomplete, and how long ago it happened. Many cell therapy trials enroll people whose injury is months or years old and medically stable. Screening generally includes a detailed neurological exam, imaging and a review of medicines and overall health, followed by a consent discussion about what the study involves and what is unknown. Checking that an offer is legitimate matters as much as medical preparation. Clinics market stem cell and other regenerative injections for spinal cord injury without proof that they work. The FDA warns that if you are being charged for one of these products, or offered it outside a clinical trial with FDA oversight, you are likely being offered a product illegally. A listing on ClinicalTrials.gov, or a company's registration with the FDA, does not by itself mean a treatment is legitimate. It is reasonable to ask whether a study runs under an FDA investigational application, who is funding it and whether participants pay anything. For stimulation programs, preparation often includes a stretch of therapy alone before stimulation starts, so the team can measure what practice achieves by itself. The programs are intensive and can last months, often at a specialized center, so travel, caregiver support and time away from work are worth planning early.
What happens depends on the approach. In cell therapy trials, the two most common methods are injecting cells directly into the injured area of the spinal cord, which requires surgery under general anesthesia, and injecting them into the fluid around the spinal cord through a needle in the lower back. Most trials use cells taken from the participant's own body, often from bone marrow, which means a separate collection procedure beforehand. Studies that use donor cells often add medicines that suppress the immune system to keep the cells from being rejected. Noninvasive stimulation is not an operation. Electrodes are placed on the skin over the spine, and a therapist adjusts the stimulation while the person practices specific tasks, such as grasping, pinching or lifting objects. The practice is the point: stimulation alone is unlikely to produce meaningful gains without it. Implanted (epidural) stimulation, still used mainly in research for standing and stepping, requires surgery to place electrodes over the spinal cord and connect them to a small battery-powered device under the skin, followed by the same kind of intensive training.
Recovery after a cell injection depends on how the cells were delivered. After surgery to inject cells into the spinal cord, people typically spend time in the hospital and then return to their rehabilitation program. After an injection into the spinal fluid, a headache is common, and a brief fever is a recognized effect of some cell types. Trial teams explain which short-lived effects to expect and which changes, such as new weakness or loss of sensation, should be reported to them right away. Any improvement, if it comes, tends to be gradual and is measured over months with repeated strength, sensation and function tests. Trials also follow participants for years to check long-term safety. With stimulation programs, gains are built session by session, and an important practical question is whether improvements hold once the program ends. Ongoing rehabilitation remains central whatever the approach, and results vary widely from person to person.
The risks depend on the approach. Injecting cells directly into the spinal cord carries surgical risks and can disturb nerve pathways that still work: in one review of published trials, a measurable loss of sensation was recorded in about 14 percent of people who had this type of injection, and it was rare after injection into the spinal fluid. Donor cells raise the possibility of rejection, which is why some studies use immune-suppressing medicines with their own side effects. With some types of stem cells, there is a theoretical risk of unwanted tissue growth, which is one reason trials follow people for a long time. Implanted stimulators can cause infection, bleeding near the spinal cord, nerve injury, movement or breakage of the electrode wires, device malfunction or loss of effect, and some people need a further operation to fix or remove the system. Noninvasive stimulation has been well tolerated in studies, but it is not free of risk. Muscle spasms, stiffness, discomfort and skin irritation under the electrodes are common. Stimulation can also trigger autonomic dysreflexia, a sudden and potentially dangerous rise in blood pressure that can affect people with injuries at the mid-back level or higher, so the team watches for it and asks people to empty their bladder and bowels before each session. Its benefits are uncertain, though: studies suggest possible gains in arm and hand function and balance, but no consistent improvement in walking, independence, muscle stiffness (spasticity) or quality of life, and the evidence is still weak. The largest avoidable risk comes from unapproved treatments sold outside regulated research. The FDA has received reports of blindness, tumors, nerve problems and serious infections after unapproved stem cell and similar products. These treatments can also be costly and may take time and money away from rehabilitation that is known to help.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Spinal Cord Regeneration, what to expect, or ask the community a question.